New York Lawmakers Pass Anti-Inversion Cannabis Bill

Bill Targets Corporate Redomiciliation Loopholes

The legislation prohibits New York-licensed cannabis operators from reincorporating in other states to circumvent local-ownership and social-equity requirements. The bill amends Article 4 of the New York Cannabis Law to add inversion-specific disqualification triggers. An "inversion" occurs when a licensee redomiciles its corporate charter to another jurisdiction while maintaining operational control in New York.

Covered transactions include mergers, asset transfers, and charter amendments that result in a change of domicile. Operators who complete such transactions without prior Office of Cannabis Management (OCM) approval face license suspension or revocation. The statute applies retroactively to transactions completed after January 1, 2025, giving OCM authority to review deals already closed.

Social Equity and Local Ownership at Stake

New York's cannabis licensing framework prioritizes justice-involved individuals, minority- and women-owned businesses, and distressed-farmer applicants—categories that could be diluted by out-of-state redomiciliation. The state's Conditional Adult-Use Retail Dispensary (CAURD) program and its successor equity tracks require majority New York ownership and operational presence. Inversions let operators maintain New York licenses while shifting legal domicile to states with lower tax burdens or more permissive corporate governance rules.

At least 14 licensed entities have redomiciled to Delaware, Nevada, or Wyoming since 2024, according to OCM filings. The agency hasn't disclosed whether any held equity-track licenses. But the legislature cited "erosion of program intent" in the bill's sponsor memo.

Tax and Regulatory Arbitrage Driving Inversions

Operators redomicile to avoid New York's corporate franchise tax and to access more flexible governance statutes in states like Delaware. New York imposes a franchise tax on business income apportioned to the state, with rates reaching 7.25% for corporations. Delaware's franchise tax is a flat fee structure based on authorized shares, often resulting in lower total liability for large-capitalization entities.

Beyond tax, Delaware's Court of Chancery offers well-developed case law on director duties and merger disputes, making it a preferred jurisdiction for MSOs anticipating M&A activity. Nevada and Wyoming offer additional privacy protections, including the ability to shield beneficial ownership from public disclosure. That feature is incompatible with New York's transparency mandates for cannabis licensees.

• New York corporate franchise tax: up to 7.25% on apportioned income
• Delaware franchise tax: $75,000 maximum annual fee for most entities
• Nevada and Wyoming: no corporate income tax; beneficial ownership shielding available

OCM Gains Retroactive Review Authority

The bill grants OCM authority to review and unwind inversions completed after January 1, 2025, even if the transactions predated the statute's enactment. Retroactive application raises potential due-process and takings questions, though the sponsor memo argues that all licenses are issued subject to ongoing regulatory compliance. Operators who redomiciled in 2025 or early 2026 must now file disclosure statements with OCM within 60 days of the bill's effective date.

Failure to disclose triggers automatic license suspension. OCM may grant waivers if the operator demonstrates that the inversion didn't materially alter ownership structure or dilute equity-program participation. The waiver standard is undefined in the statute, leaving OCM discretion to develop criteria through rulemaking.

Governor's Signature Expected; Effective Date Unclear

Governor Kathy Hochul hasn't commented publicly on the bill, but her office supported similar anti-inversion language in the 2025-2026 executive budget proposal. The legislature's version is narrower. It applies only to cannabis licensees rather than all New York corporations. If signed, the bill takes effect immediately, though OCM has indicated it'll publish a 90-day safe-harbor period for voluntary disclosures.

Industry observers expect the bill to face legal challenge on Commerce Clause and retroactivity grounds. No operator has announced litigation plans as of June 4, 2026.

Implications for MSOs and Equity Operators

Multi-state operators with New York licenses may need to reverse recent redomiciliations or risk losing market access in the state's $2.1 billion adult-use market. For equity-track licensees, the bill reinforces the state's commitment to local ownership, though it doesn't address federal tax burdens under IRC §280E that continue to pressure margins regardless of domicile.

The statute's retroactive reach creates immediate compliance risk for operators who redomiciled in 2025, particularly those who did so to facilitate out-of-state financing or M&A transactions.

For full background on New York's licensing framework and ongoing regulatory developments, see the CannIntel topic hub on New York Cannabis Program.

What to Watch

OCM rulemaking on waiver criteria and disclosure forms will determine how aggressively the agency enforces the statute. Legal challenges, if filed, will likely focus on the bill's retroactive application and whether it imposes an unconstitutional condition on interstate commerce. The first disclosure deadline falls 60 days after the governor's signature.